Literature DB >> 15541320

Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result.

Mary McNaughton-Collins1, Floyd J Fowler, Jean-Francois Caubet, David W Bates, Jeong Min Lee, Alison Hauser, Michael J Barry.   

Abstract

PURPOSE: To evaluate the psychological implications of an apparently false-positive screening result for prostate cancer.
METHODS: The sample comprised 167 men with a benign biopsy result in response to a suspicious screening test result (biopsy group) and 233 men with a normal prostate-specific antigen (PSA) test result (control group). The men responded to a questionnaire within about 6 weeks of their biopsy or PSA results. They were asked about demographic characteristics, medical history, psychological effects, biopsy experience, and prostate cancer knowledge.
RESULTS: The survey response rate was 85% (400/471). The mean (+/- SD) age of respondents was 60 +/- 9 years (range, 40 to 88 years); 88% (n = 350) were white. Forty-nine percent (81/167) of men in the biopsy group reported having thought about prostate cancer either "a lot" or "some of the time", compared with 18% (42/230) in the control group (P < 0.001). In addition, 40% (67/167) in the biopsy group reported having worried "a lot" or "some of the time" that they may develop prostate cancer, compared with 8% (18/231) in the control group (P < 0.001).
CONCLUSION: Men who underwent prostate biopsy more often reported having thought and worried about prostate cancer, despite having received a benign result. This underrecognized human cost of screening should be considered in the debate about the benefits and harms of prostate cancer screening.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541320     DOI: 10.1016/j.amjmed.2004.06.036

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  22 in total

1.  Optimization of PSA screening policies: a comparison of the patient and societal perspectives.

Authors:  Jingyu Zhang; Brian T Denton; Hari Balasubramanian; Nilay D Shah; Brant A Inman
Journal:  Med Decis Making       Date:  2011-09-20       Impact factor: 2.583

Review 2.  Principles of cancer screening: lessons from history and study design issues.

Authors:  Jennifer M Croswell; David F Ransohoff; Barnett S Kramer
Journal:  Semin Oncol       Date:  2010-06       Impact factor: 4.929

Review 3.  Clinically localised prostate cancer.

Authors:  Timothy J Wilt; Ian M Thompson
Journal:  BMJ       Date:  2006-11-25

4.  Factors influencing behavioral intention regarding prostate cancer screening among older African-American men.

Authors:  Marvella E Ford; Sally W Vernon; Suzanne L Havstad; Shirley A Thomas; Shawna D Davis
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

5.  Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer.

Authors:  Satoru Kawakami; Nobuhiko Hyochi; Junji Yonese; Masataka Yano; Yasuhisa Fujii; Yukio Kageyama; Iwao Fukui; Kazunori Kihara
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

6.  The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.

Authors:  Floyd J Fowler; Michael J Barry; Beth Walker-Corkery; Jean-Francois Caubet; David W Bates; Jeong Min Lee; Alison Hauser; Mary McNaughton-Collins
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

7.  Prostate-specific antigen (PSA) screening rates and factors associated with screening in Eastern Canadian men: Findings from cross-sectional survey data.

Authors:  Devan Tchir; Marwa Farag; Michael Szafron
Journal:  Can Urol Assoc J       Date:  2020-07       Impact factor: 1.862

8.  Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result.

Authors:  R C Macefield; C Metcalfe; J A Lane; J L Donovan; K N L Avery; J M Blazeby; L Down; D E Neal; F C Hamdy; K Vedhara
Journal:  Br J Cancer       Date:  2010-04-06       Impact factor: 7.640

9.  A test of knowledge about prostate cancer screening. Online pilot evaluation among Southern California Physicians.

Authors:  Douglas S Bell; Ron D Hays; Jerome R Hoffman; Frank C Day; Jerilyn K Higa; Michael S Wilkes
Journal:  J Gen Intern Med       Date:  2006-02-22       Impact factor: 5.128

10.  The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?

Authors:  Deepak Dubey
Journal:  Indian J Urol       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.